Randomized Controlled Trial
Copyright ©The Author(s) 2021.
World J Diabetes. Mar 15, 2021; 12(3): 292-305
Published online Mar 15, 2021. doi: 10.4239/wjd.v12.i3.292
Table 5 Results of intention-to-treat analysis for primary and secondary outcomes
VariableBaseline
2 mo
6 mo
12 mo
Significance level
CBTControlCBTControlCBTControlCBTControlConditionTimeInteraction
PSQI score10.07 (2.38)10.04 (2.37)9.36 (2.77)9.92 (2.44)9.45(2.75)9.95 (2.59)9.07 (2.69)9.94 (2.40)< 0.001< 0.001< 0.001
HbA1c value7.44 (1.12)7.50 (1.11)7.46 (1.10)7.49 (1.15)7.27 (1.18)7.44 (1.20)7.23 (1.17)7.61 (1.16)< 0.0010.028< 0.001